FDC
|
The Current P/S Ratio of FDC is 2.59.
| Share Price | ₹348.2 | Aug 21,2026 |
| Market Cap | ₹5,668.7 Cr | |
| Sales-TTM | ₹2,190.2 Cr | TTM-Consolidated Results |
| Price/Sales | 2.59x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of FDC
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹5,668.7 Cr] as on Aug 21,2026
(/) Sales [ ₹2,190.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.59x ]
Thus, for FDC , the investors are currently willing to pay '2.59 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of FDC !
The chart below summarizes the trend in P/S Ratio of FDC over the last five years.
Historical PS (Price/Sales) ratio chart of FDC
PS Ratio Performance Analysis for FDC
- FDC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.09x.
- FDC 's operated at median p/e ratio of 3.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/e ratio peaked in Mar2021 at 3.62x.
- FDC 's p/e ratio hit its five-year low in Mar2023 of 2.39x.
How does FDC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| FDC | 2,190.2 | 2.59 | 5,668.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 456,090.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.21 | 226,976.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.81 | 185,639.0 |
| CIPLA LTD | 28,324.4 | 4.07 | 115,216.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.95 | 98,074.4 |
| MANKIND PHARMA LTD | 14,737.9 | 6.65 | 97,962.6 |
| LUPIN LTD | 29,966.6 | 3.35 | 100,272.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.91 | 111,720.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.67 | 93,208.3 |
| LAURUS LABS LTD | 7,269.6 | 13.49 | 98,047.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs FDC 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.59x |
| Max industry PS | 20.21x |
| Median industry PS | 4.07x |
| Average industry PS | 7.21x |
You may also like the below Video Courses